Loading clinical trials...
Loading clinical trials...
Objective of this study is to determine the clinical benefits of trimetazidine in improvement of MASLD
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
October 6 University
NCT07122700 · Metabolic Associated Fatty Liver Disease, Metabolic Associated Steatotic Liver Disease, and more
NCT05782972 · Metabolic Associated Fatty Liver Disease
NCT06764056 · Metabolic Associated Fatty Liver Disease, Metabolic Associated-dysfunction Steatohepatitis (MASH), and more
NCT05738707 · Metabolic Associated Fatty Liver Disease
NCT04871880 · Metabolic Associated Fatty Liver Disease
Beni-Suef university
Banī Suwayf, Beni Suweif Governorate
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions